The mission of SDK Therapeutics is to develop and commercialize medicines in hematology, oncology, and rare disease to improve the life of patients.
Company Details
- Employees
- 3
- Founded
- -
- Address
- The Significant Treatment Burden Associated With The Current Intravenous Formulation. The Sdk Team Is On Track To File An Ind In 2024 And Initiate Sdk001 Clinical Program In Q1 2025. More Exciting News To Be Shared Shortly.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://sdktx.com/
- Keywords
- Hematology, Oncology, Rase Diseases.
Sdk Therapeutics Questions
Sdk Therapeutics's website is https://sdktx.com/
Sdk Therapeutics's LinkedIn profile is https://www.linkedin.com/company/sdk-therapeutics
Sdk Therapeutics has
3 employees.
View email and phone details for 3
employees at Sdk Therapeutics.
Sdk Therapeutics's industry is
Biotechnology Research
Sdk Therapeutics's top competitors are
Ono Pharma Usa,
Bristol Myers Squibb,
Novocure,
Alnylam Pharmaceuticals,
Summit Therapeutics, Inc.,
Immunovant,
Gilead Sciences,
Cv Sciences, Inc.,
Symbio Pharma Usa, Inc.,
Elevar Therapeutics.
Sdk Therapeutics's categories are Biotechnology Research
Sdk Therapeutics's founding year is 2024
